These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 10832149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E.
    Ital Heart J Suppl; 2000 Apr; 1(4):579-80. PubMed ID: 10832150
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 5. [Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required].
    Jensen SM, Kesek M.
    Lakartidningen; 2000 Dec; 106(48):3236, 3238-41. PubMed ID: 20101834
    [No Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A, AVID Investigators.
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [Abstract] [Full Text] [Related]

  • 7. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E.
    J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
    [Abstract] [Full Text] [Related]

  • 8. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A, Epstein AE, Herre JM, Klein RC, Platia EV, Wilkoff B, Ledingham RB, Greene HL, Hallstrom AP, DAVID Investigators.
    Am J Cardiol; 2005 Jun 15; 95(12):1431-5. PubMed ID: 15950565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar 15; 1(1):43-7, AXIV. PubMed ID: 12132492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C, Leitner L, Siebermair J, Pezawas T, Stix G, Kastner J, Schmidinger H.
    Int J Cardiol; 2013 Sep 10; 167(6):3006-10. PubMed ID: 23017814
    [Abstract] [Full Text] [Related]

  • 18. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P.
    Ital Heart J Suppl; 2000 Aug 10; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R, Cinca J, Marber M.
    Eur Heart J; 1999 Mar 10; 20(6):397-8. PubMed ID: 10213339
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.